Effect of Sodium Alginate on Gastrointestinal Symptoms after Esophagogastroduodenoscopy with Biopsy: Randomized Controlled Trial
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: After esophagogastroduodenoscopy (EGD) with biopsy, some patients experience gastrointestinal symptoms. This study investigated the effect of sodium alginate on biopsy-related gastrointestinal symptoms. Methods: In this open-label, randomized, controlled trial, patients undergoing EGD with biopsy were randomly assigned to a treatment or control group. In the treatment group, sodium alginate was orally administered for 3 days after EGD. Patients completed questionnaires about their gastrointestinal symptoms at baseline (past week), the day after returning home, and after another 3 days. Gastrointestinal symptoms, including abdominal pain, epigastric pain/soreness, heartburn, acid reflux, nausea/vomiting, borborygmus, abdominal distension, and belching, were rated using an upper gastrointestinal symptom rating scale (GSRS). Results: A total of 210 persons (138 men) who underwent EGD with biopsy were enrolled and allocated to the treatment (n=104) or control (n=106) group. At baseline, the demographic factors and GSRS scores were not different between the control and treatment groups. The epigastric pain/soreness score increased in the control group after endoscopic biopsy (+0.056), whereas the score was decreased in the treatment group (–0.067) (p=0.042). In the treatment group, the scores for acid regurgitation and epigastric soreness decreased during follow-up from those at baseline (p<0.05), whereas there were no significant reductions in the control group. The scores for belching and borborygmus decreased during follow-up only in the treatment group. Abdominal bloating decreased in both the control and treatment groups. Conclusions: Sodium alginate reduced epigastric pain/soreness after EGD with biopsy. Therefore, the prescription of sodium alginate should be considered after endoscopic biopsy.
Abstract
Background/Aims: After esophagogastroduodenoscopy (EGD) with biopsy, some patients experience gastrointestinal symptoms. This study investigated the effect of sodium alginate on biopsy-related gastrointestinal symptoms. Methods: In this open-label, randomized, controlled trial, patients undergoing EGD with biopsy were randomly assigned to a treatment or control group. In the treatment group, sodium alginate was orally administered for 3 days after EGD. Patients completed questionnaires about their gastrointestinal symptoms at baseline (past week), the day after returning home, and after another 3 days. Gastrointestinal symptoms, including abdominal pain, epigastric pain/soreness, heartburn, acid reflux, nausea/vomiting, borborygmus, abdominal distension, and belching, were rated using an upper gastrointestinal symptom rating scale (GSRS). Results: A total of 210 persons (138 men) who underwent EGD with biopsy were enrolled and allocated to the treatment (n=104) or control (n=106) group. At baseline, the demographic factors and GSRS scores were not different between the control and treatment groups. The epigastric pain/soreness score increased in the control group after endoscopic biopsy (+0.056), whereas the score was decreased in the treatment group (–0.067) (p=0.042). In the treatment group, the scores for acid regurgitation and epigastric soreness decreased during follow-up from those at baseline (p<0.05), whereas there were no significant reductions in the control group. The scores for belching and borborygmus decreased during follow-up only in the treatment group. Abdominal bloating decreased in both the control and treatment groups. Conclusions: Sodium alginate reduced epigastric pain/soreness after EGD with biopsy. Therefore, the prescription of sodium alginate should be considered after endoscopic biopsy.
참고문헌 (18)
- Yuki T, "Bleeding risk related to upper gastrointestinal endoscopic biopsy in patients receiving antithrombotic therapy : a multicenter prospective observational study", Curr Ther Res Clin Exp, 84, pp.32~36 (2017)
- Daigo K, "Pharmacological studies of sodium alginate. I. Protective effect of sodium alginate on mucous membranes of upper-gastrointestinal tract", Yakugaku Zasshi, 101, pp.452~457 (1981)
- Diago K, "Pharmacological studies of sodium alginate. V. Effect of sodium alginate on platelet aggregation", Yakugaku Zasshi, 105, pp.171~182 (1985)
- Daigo K, "Pharmacological studies of sodium alginate. II. Hemostatic effect of sodium alginate on gastrointestinal bleeding", Yakugaku Zasshi, 101, pp.458~463 (1981)
- Manabe N, "Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease : a randomized clinical trial", Dis Esophagus, 25, pp.373~380 (2012)
- Poynard T, "Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux", Aliment Pharmacol Ther, 12, pp.159~165 (1998)
- Yamamoto A, "Sodium alginate ameliorates indomethacin-induced gastrointestinal mucosal injury via inhibiting translocation in rats", World J Gastroenterol, 20, pp.2641~2652 (2014)
- Humphreys ER, "Absorption by the rat of alginate labelled with carbon-14", Nature, 219, pp.1172~1173 (1968)
- Svedlund J, "GSRS : a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease", Dig Dis Sci, 33, pp.129~134 (1988)
- Hoffmann W, "Regeneration of the gastric mucosa and its glands from stem cells", Curr Med Chem, 15, pp.3133~3144 (2008)
- Yeomans ND, "Regeneration of gastric mucosa after aspirin-induced injury in the rat", Am J Dig Dis, 18, pp.773~780 (1973)
- Helpap B, "Repair of gastric ulcer : a cell kinetic study", Virchows Arch A Pathol Anat Histol, 392, pp.159~170 (1981)
- Tseng WH, "Double-blind, placebocontrolled study with alginate suspension for laryngopharyngeal reflux disease", Laryngoscope, 128, pp.2252~2260 (2018)
- Talley NJ, "Functional dyspepsia", N Engl J Med, 373, pp.1853~1863 (2015)
- Daigo K, "Pharmacological studies of sodium alginate. III. Acceleration of fibrin formation by sodium alginate", Yakugaku Zasshi, 101, pp.464~469 (1981)
- Yamamoto A, "Sodium alginate inhibits methotrexate-induced gastrointestinal mucositis in rats", Biol Pharm Bull, 36, pp.1528~1534 (2013)
- Thomas JG, "In vitro antimicrobial efficacy of a silver alginate dressing on burn wound isolates", J Wound Care, 20, pp.124~128 (2011)
- Thomas S, "Alginate dressings in surgery and wound management : part 1", J Wound Care, 9, pp.56~60 (2000)